Blocklisting Six Monthly Return

RNS Number : 5294W

Hutchison China Meditech Limited

30 December 2013

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Blocklisting Six Monthly Return

London: Monday, 30 December 2013: Chi-Med announces the following blocklisting six monthly return:

1.	Name of applicant:		Hutchison China MediTech Limited
2.	Name of scheme:		Hutchison China MediTech Limited Share Option Scheme
3.	Period of return:		From 29 June 2013 to 28 December 2013
4.	Balance under scheme from previous return:		1,721,279 ordinary shares of US$1 each
5.	The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:		Nil
6.	Number of securities issued/allotted under scheme during period:		Nil
7.	Balance under scheme not yet issued/allotted at end of the period:		1,721,279 ordinary shares of US$1 each
8.	Number and class of securities originally listed and the date of admission:		2,560,606 ordinary shares of US$1 each admitted on 26 June 2007
9.	Total number of securities in issue at the end of the period:		52,051,448 ordinary shares of US$1 each
Name of contact:			Christian Hogg
Address of contact:			21/F., Hutchison House, 10 Harcourt Road, Hong Kong
Telephone number of contact:			[phone]

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:      [phone]
Panmure Gordon (UK) Limited	Telephone:      [phone]
Richard Gray Andrew Potts Grishma Patel
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:      [phone] Mobile:             [phone] Mobile:             [phone]

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited. For more information, please visit: www.chi-med.com.

 

END

 

 

BLRURVNROUAUORA